Companies / OS Therapies Inc
OS Therapies Inc
NYSE: OSTXCIK 1795091ROCKVILLE, MD
Financials
Ownership
44.5M shares outstanding · as of May 14, 2026
Ownership
| Institutions | 4.58% | 2,038,535 |
| Public float | 95.42% | 42,499,571 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 8
View all →| Insider | % of shares | Shares |
|---|---|---|
Acevedo Christopher P.Chief Financial Officer | — | — |
Ciccio JohnDirector | — | — |
Galzahr KarimFormerDirector | — | — |
Jarry Olivier RogerDirector | — | — |
McKean-Dieser Avril SuzetteDirector | — | — |
Petit RobertSee Remarks | — | — |
Romness Paul A.CEOPresident and CEO · Director | — | — |
Search Theodore F.Director | — | — |
Institutional holders 27
View all →| Holder | Value | % of shares |
|---|---|---|
| $756.6K | 1.21% | |
| $560.0K | 0.90% | |
| $460.7K | 0.54% | |
| $394.9K | 0.63% | |
| $228.2K | 0.27% | |
| $153.9K | 0.25% | |
| $99.8K | 0.16% | |
| $45.1K | 0.07% | |
| $43.1K | 0.07% | |
| $38.8K | 0.06% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jan 22, 2026 | McKean-Dieser Avril Suzette Director | Grant | Stock options (right to buy) | — | +50K | 50,000 0.11% of shares | low |
| Jan 22, 2026 | Search Theodore F. Director | Grant | Stock options (right to buy) | — | +50K | 50,000 0.11% of shares | low |
| Jan 22, 2026 | Ciccio John Director | Grant | Stock options (right to buy) | — | +50K | 50,000 0.11% of shares | low |
| Jan 22, 2026 | Acevedo Christopher P. Executive | Grant | Stock options (right to buy) | — | +100K | 100,000 0.22% of shares | low |
| Jan 22, 2026 | Petit Robert Executive | Grant | Stock options (right to buy) | — | +100K | 100,000 0.22% of shares | low |
| Jan 22, 2026 | Romness Paul A. CEO | Grant | Stock options (right to buy) | — | +1.0M | 1,000,000 2.25% of shares | low |
| Jan 22, 2026 | Jarry Olivier Roger Director | Grant | Stock options (right to buy) | — | +50K | 50,000 0.11% of shares | low |
| Jan 22, 2026 | Galzahr Karim Director | Grant | Stock options (right to buy) | — | +50K | 50,000 0.11% of shares | low |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| OSTX | Common Stock | 68764Y207 |